PAPADOPOULOS STELIOS 4

What Happened

• Stelios Papadopoulos, a director of Exelixis, Inc. (EXEL), received an award of 8,367 restricted stock units (RSUs) on May 27, 2026 under the Exelixis, Inc. 2017 Equity Incentive Plan. The RSUs were granted at $0.00 per share (no cash consideration) and therefore have a transaction value reported as $0.
• Each RSU is the economic equivalent of one share of Exelixis common stock. The award will vest 100% on May 27, 2027, subject to Papadopoulos’s continued service through that date.

Key Details

• Transaction date: 2026-05-27; Transaction type: Award/Grant (code A); Price reported: $0.00.
• Shares involved: 8,367 RSUs (each corresponds to one share upon vesting).
• Vesting: 100% on May 27, 2027, contingent on continuous service (per footnote).
• Footnotes: F1 describes the RSU grant under the 2017 Equity Incentive Plan and the vesting schedule; F2 confirms the 8,367 shares will be issued upon vesting.
• Filing does not report cash paid (none) and does not indicate immediate sale or exercise; this is a compensation award rather than a market purchase or sale.

Context

• RSU grants are a form of equity compensation and typically reflect long-term incentive pay; they do not represent an immediate purchase or sale and should not be interpreted alone as a direct bullish or bearish signal.
• For retail investors: awards like this increase potential future dilution when they vest and shares are issued; they are common for directors and executives as part of pay package.